SUGT1

Protein SGT1 homolog · Q9Y2Z0 · SUGT1 on Sugi Atlas →

0 patent compounds predicted against SUGT1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SUGT1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Cornelia De Lange Syndrome: Assessing Positive Effects of Lithium Treatment PHASE2/PHASE3RECRUITING
A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE) PHASE1/PHASE2RECRUITING
Vaccine Treatment for Advanced Non-Small Cell Lung Cancer PHASE1/PHASE2COMPLETED
NEO100 and High-Grade Meningioma PHASE2RECRUITING
Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma PHASE2RECRUITING
A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed Chondrosarcomas PHASE2SUSPENDED
Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer PHASE2COMPLETED
Safety and Impact of Dasatinib on Viral Persistence and Inflammation in People With HIV Under Antiretroviral Treatment PHASE2COMPLETED
Selinexor With ICE Chemotherapy in Secondary Central Nervous System Involving B-cell Non-Hodgkin Lymphoma PHASE1/PHASE2RECRUITING
A Phase I Study of Systemic Gene Therapy With SGT-94 in Patients With Solid Tumors PHASE1COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Safety, Tolerability and Pharmacokinetics of Benfo-Oxythiamine (B-OT) in Healthy Volunteers PHASE1COMPLETED
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
A Study of the Interaction Between Tumor Susceptibility Gene Glycine N-methyltransferase (GNMT) and Lung Cancer nanUNKNOWN
Assessment Of Long Noncoding RNA CCAT1 In Colorectal Cancer Patients nanUNKNOWN
Thermogenic Silencer Regulatory Factors in Humans nanACTIVE_NOT_RECRUITING
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Investigate eNAMPT in Multiple Myeloma Biology and Establish Its Role in Disease Progression nanCOMPLETED
Steroid Treatment of Idiopathic Nephrotic Syndrome nanCOMPLETED
Effects of Cardiac Rehabilitation on High Mobility Group Box-1 Levels After Acute Myocardial Infarction nanCOMPLETED
Expression of Altered Glycosyltransferases, Mucins, and RTKs in Human Ovarian and Endometrial Cancers nanUNKNOWN
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants. nanUNKNOWN
Evaluation of Prognostic Factors: From Breast Cancer to Bone Metastases nanUNKNOWN
Polycystic Ovary Syndrome in Type 1 Diabetes nanNOT_YET_RECRUITING
LncRNA Nicotinamide Nucleotide Transhydrogenase-Antisense RNA1 NNT-AS1 in CRC nanCOMPLETED
Epidemiology of Atherosclerosis nanCOMPLETED
is the Sclerostin Marker of Chronic Periodontitis nanCOMPLETED
Histoblood Group Antigens as a Risk Factor of Asthma nanCOMPLETED
Treatment of Chronic Lymphocytic Leukemia nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a SUGT1 binder may also engage these)

ProteinNameSimilarity
Q2KIK0 0.993 Q2KIK0 →
B0BN85 0.986 B0BN85 →
Q9CX34 0.985 Q9CX34 →
Q9SUR9 0.978 Q9SUR9 →
Q0JL44 0.972 Q0JL44 →
Q4R4P3 0.966 Q4R4P3 →
Q4R3F0 0.963 Q4R3F0 →
Q17QG2 0.962 Q17QG2 →
Q8R368 0.962 Q8R368 →
A0A3L6DPG1 0.962 A0A3L6DPG1 →
Q5R6Z8 0.962 Q5R6Z8 →
Q86X45 0.962 Q86X45 →
Q5VJS5 0.961 Q5VJS5 →
Q6AYK6 0.960 Q6AYK6 →
Q63525 0.960 Q63525 →
NUDC Nuclear migration protein nudC 0.959 landscape →
Q5GFD9 0.959 Q5GFD9 →
Q8WXU2 0.958 Q8WXU2 →
Q90ZA1 0.958 Q90ZA1 →
O88978 0.958 O88978 →
Q863A4 0.958 Q863A4 →
HSPH1 Heat shock protein 105 kDa 0.957 landscape →
Q8NHP6 0.957 Q8NHP6 →
Q5M8G6 0.957 Q5M8G6 →
Q9QXN3 0.957 Q9QXN3 →
Q1RMR5 0.956 Q1RMR5 →
Q0IIM3 0.956 Q0IIM3 →
Q6DKA1 0.956 Q6DKA1 →
Q60446 0.956 Q60446 →
Q5XH48 0.956 Q5XH48 →